Subcutaneous Injection of Botulinum Toxin A Is Beneficial in Postherpetic Neuralgia

Abstract

Subcutaneous administration of BTX-A significantly decreased pain in PHN and reduced opioid use compared with lidocaine and placebo at day 7 and 3 months post-treatment. It also increased subjects' sleep times.